Lab guide · Short peptides & copper complexes
What Is GHK-Cu? Copper-Binding Peptide Research Overview
What is GHK-Cu? It is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, first isolated from human plasma in 1973. This guide covers its coordination chemistry, discovery, the pathways reported in cell and animal studies, and the limits of the evidence.
Key takeaways
- GHK-Cu is the copper(II) complex of the tripeptide Gly-His-Lys; PubChem lists the complex at about 402.9 g/mol and the free peptide at about 340.4 g/mol.
- GHK was described in 1973 as an activity in human plasma albumin and was later shown to bind copper with high affinity.
- Reported effects on extracellular matrix, angiogenesis and gene expression come from cell, animal and computational analyses.
- Database records describe more than one copper stoichiometry, so batch documentation should state exactly which species was tested.
What is GHK-Cu?
So, what is GHK-Cu? GHK is a naturally occurring tripeptide, glycyl-L-histidyl-L-lysine, and GHK-Cu is its copper(II) complex. The peptide was first isolated by Loren Pickart in 1973 as an activity in human albumin that made old liver tissue synthesise proteins like younger tissue, and later work established it as the tripeptide with a strong affinity for copper (Pickart et al., 2015). It is also a widely used cosmetic ingredient, listed as copper tripeptide-1.
Research use only. This overview summarises published laboratory and animal research. Baltic Peptides supplies this compound for in-vitro and preclinical research by qualified researchers; it is not a medicine and is not for human or veterinary use.
Chemical structure and specifications
| Property | Value |
|---|---|
| Sequence | H-Gly-His-Lys-OH (GHK) |
| Free peptide formula | C14H24N6O4, ≈340.4 g/mol |
| Copper complex (PubChem record) | C14H23CuN6O4+, 402.92 g/mol |
| CAS number (complex) | 89030-95-5 |
| Appearance | Blue to blue-violet powder (copper(II) complex) |
The complex and CAS number match the PubChem record for prezatide copper, and PubChem records the parent peptide separately. Copper(II) is held by the histidine imidazole, the N-terminal amine and a backbone amide nitrogen, which gives the complex its blue colour. Other PubChem entries describe a 2:1 peptide-to-copper complex at about 744.3 g/mol, so a batch report should state which species was tested.
Discovery and research history
Pickart and colleagues proposed in 1980 that the plasma tripeptide may work by facilitating copper uptake into cells, a paper cited in the 2015 review. Research then moved through wound healing, skin remodelling and tissue repair, and the review notes that GHK has been tested in skin, lung connective tissue, bone, liver and stomach-lining models (Pickart and Margolina, 2018).
In the 2010s the group published gene-expression analyses suggesting that GHK alters the expression of a large number of human genes, including those relevant to nervous-system function (Pickart et al., 2017).
Proposed mechanisms and pathways
Copper delivery
GHK binds Cu(II) with high affinity and is proposed to carry copper to cells in a non-toxic form. This is the central hypothesis from the original studies, and the chemistry of binding is well characterised.
Matrix, repair and gene-expression findings
Cell and animal studies associate GHK-Cu with collagen, elastin and glycosaminoglycan synthesis, balanced matrix-metalloproteinase activity, angiogenesis and anti-inflammatory effects. The broad gene-expression findings are hypothesis-generating: they describe patterns of changed expression rather than a single receptor or pathway, and no single mechanism is established.
Main research areas
- Extracellular matrix: collagen and elastin synthesis and MMP/TIMP balance in fibroblast and skin models.
- Wound healing and angiogenesis: re-epithelialisation and new vessel formation in wound models.
- Gene expression: computational and cell-based analyses of transcript changes.
- Copper biology: how small copper-binding peptides move copper between plasma proteins and cells.
What published studies actually show
| Evidence type | What is reported |
|---|---|
| Chemical facts | Sequence, copper coordination and database masses are verifiable. |
| Cell studies | Fibroblast matrix synthesis and altered expression of many genes. |
| Animal studies | Improved wound and tissue-repair endpoints in several organ models, reported mainly by one group of authors. |
| Human research | Most published human work concerns topical cosmetic formulations, which is a different context from a research-grade lyophilised peptide. |
| Unconfirmed | A single receptor, the extent of copper delivery in vivo and the claimed age-related decline in plasma GHK as a cause of any change. |
Scientific limitations and open questions
- Much of the broad-pathway literature comes from a small group of authors, and independent replication is limited.
- Gene-expression analyses show associations, not causal mechanisms.
- Copper stoichiometry varies between database records and products.
- Cosmetic and topical data cannot be extrapolated to other forms.
- Claims about age-related decline in plasma GHK are reported by the discovering group and are not independently settled.
Analytical and laboratory considerations
Mass spectrometry can confirm the peptide (340.4 Da) and the copper complex, and the blue colour is a quick visual check that copper is bound. Chelating agents such as EDTA, strong acids and reducing agents can strip or reduce the copper, so buffer composition matters in experiments.
See how to store peptides and the guide to reading a peptide COA. Batch reports are on the COA page, and formats are on the GHK-Cu product page.
Sources and further reading
- Pickart L., Vasquez-Soltero J.M. and Margolina A. (2015). GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Res Int. PMC full text
- Pickart L. and Margolina A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci 19(7):1987. PubMed
- Pickart L. et al. (2017). The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. PMC full text
- PubChem record for prezatide copper (GHK-Cu). PubChem
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article summarises published research for educational purposes only and does not describe any use in people.
FAQ
Common questions
What is GHK-Cu?
What does GHK stand for?
What is the molecular weight and CAS number of GHK-Cu?
Why is GHK-Cu blue?
Who discovered GHK?
Is GHK-Cu the same as a cosmetic copper peptide?
Is there human clinical evidence for GHK-Cu?
Keep reading
Related reading
GHK-Cu
Current batches, formats and the COA for GHK-Cu.
What is Glutathione?
Another well-studied tripeptide, with a redox rather than copper-binding role.
Peptide blends explained
Why component research does not define a combined formulation.
Research-grade GHK-Cu, tested before it ships
Independent HPLC and mass spec results for every batch, dispatched from the EU.
